Literature DB >> 2991253

Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily.

E V Prochownik, S C Bock, S H Orkin.   

Abstract

Antithrombin III (ATIII) plays an integral role in the coagulation system by inhibiting thrombin and several other activated clotting factors. Inherited deficiency of ATIII is quite common and can result in life-threatening thrombotic complications. In order to understand the basis of ATIII deficiency, we have isolated and characterized the normal human ATIII gene from a recombinant Charon 4A bacteriophage genomic library. The ATIII gene contains six exons and five introns distributed over approximately 19 kilobases of DNA. The positions of introns in the ATIII gene were compared with other members of the serine protease inhibitor family which share 17-31% amino acid homology. When aligned to achieve maximal protein homology, only one of the ATIII introns corresponded to the four introns of rat angiotensinogen or human alpha 1-antitrypsin. Similarly, only one ATIII intron was homologous to the seven introns of chicken ovalbumin. We present two testable models to explain the discrepancy in intron positions among members of the serine protease inhibitor superfamily of genes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991253

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

2.  A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.

Authors:  D White; G Abraham; C Carter; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

3.  Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease.

Authors:  D J Perry; R W Carrell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

4.  A novel missense mutation in the antithrombin III gene (Ser349----Pro) causing recurrent venous thrombosis.

Authors:  C B Grundy; S Holding; D S Millar; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

5.  Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene.

Authors:  I Gaillard-Sanchez; M G Mattei; E Clauser; P Corvol
Journal:  Hum Genet       Date:  1990-03       Impact factor: 4.132

6.  cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

Authors:  D Ginsburg; R Zeheb; A Y Yang; U M Rafferty; P A Andreasen; L Nielsen; K Dano; R V Lebo; T D Gelehrter
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  Do exons code for structural or functional units in proteins?

Authors:  T W Traut
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2.

Authors:  T Hayashi; M Usui; J Nishioka; Z X Zhang; K Suzuki
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

9.  Organization of the human alpha 2-plasmin inhibitor gene.

Authors:  S Hirosawa; Y Nakamura; O Miura; Y Sumi; N Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1.

Authors:  G D Billingsley; M A Walter; G L Hammond; D W Cox
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.